How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke
According to a recently published study by Bayer Consumer Health, being poor makes it more likely that you will suffer from self-treatable health cond...
Scrip's Five Must-Know Things - July 7, 2025
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 4, 2025. In this episode: AbbVie’s big autoimmune CA...
【3分で解説 世界のファーマ】第24回 トランプ関税 製薬大国インドへの影響 (Japanese-language podcast)
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら Snapshot Of India’s Pharma Manu...
ADDF's Karen Harris: Investing in Alzheimer's Like a VC
How is venture philanthropy revolutionizing Alzheimer's drug discovery? We sit down with Karen Harris, CFO at the Alzheimer's Drug Discovery Foundatio...
China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss
In the first episode of this new China Biopharma English-language mini podcast, Shanghai-based senior reporter Xu Hu looks at the main directions in w...
Datamonitor Healthcare Podcast: ASCO 2025
Summer Colling and Emma Wille speak with oncology experts Nkiru Ibeanu, Neha Anand, Anna Simmons and David Dahan about the 2025 American Society of Cl...
Weathering the Storm: Love, Laws, and Global Trials [FDA Regulations & Biotech in 2025]
With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing rea...
Scrip's Five Must-Know Things - June 30, 2025
Audio roundup of selected biopharma industry content from Scrip over the business week ended June 27, 2025. In this episode: top drugs in the first qu...
Post-BIO Podcast: Thoughts From The Frontlines
Join Scrip editors Mandy Jackson and Mary Jo Laffler and Pink Sheet editor Sarah Karlin-Smith as they discuss the general mood at the recent BIO Inter...
Navigating Regulatory Uncertainty: Diversity Action Plans
The FDA’s Diversity Action Plan guidance underwent several changes in recent months—with the draft guidance taken down, restored, and then pulled agai...